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Abstract 
Biocompatible synthetic polymers are largely used in the bio-medical domain, tissue engineering and in controlled release 
of medicines. Polymers can be used in the achievement of cardiac and vascular devices, mammary implants, eye lenses, surgical 
threads, nervous conduits, adhesives, blood substitutes, etc. Our study was axed on the development of cytotoxicity tests for 3 
synthetic polymers, namely polyvinyl alcohol, polyethylene glycol and polyvinyl chloride. These tests targeted to determine the 
viability and morphology of cells (fibroblasts) that were in indirect contact with the studied polymers. Cell viability achieved for all the 
studied synthetic polymers allowed their frame in biocompatible material category. Cell morphology did not significantly change, thus 
accomplishing a new biocompatibility criterion. The degree of biocompatibility of the studied polymers varied. Polyvinyl alcohol 
presented the highest grade of biocompatibility and polyvinyl chloride placed itself at the lowest limit of biocompatibility. The results 
achieved allowed the selection of those polymers that (by enhancing their degrees of biocompatibility due to the association with 
various biopolymers) will be used in the development of new biocompatible materials, useful in nervous conduits manufacture.  
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Introduction 
Polymers are organic materials, composed of a 
large number of macromolecules, which in fact form 
covalent atom bindings. Due to the covalent nature of 
intermolecular bindings, the electrons are located 
between the atoms and consequently the polymers tend 
to have low thermal and electric properties. Polymer 
thermal and mechanic conduct is influenced by the 
chemical composition, polymer chain structure and the 
atomic weight of the molecules. The number of polymer 
biomaterials is quite high. They differ by monomer 
chemical nature, polymerisation grades and conditions, 
molecular weight, steric structure, additives and the 
presence of foreign bodies [1]. By considering tissue 
reactions of all implant materials as foreign body 
reactions, the destination of a certain material is 
determined by the intensity of the interactions and 
irritability capacity [2-4].  
The biocompatibility of a material is defined as 
the material property, which, after implantation in a living 
organism, does not produce adverse reactions and is 
accepted by the adjacent tissues. Thus, the implant 
material must not present toxicity and must not induce 
inflammatory reactions [5,6]. Implant biocompatibility 
depends on numerous factors, such as the patient’s 
health status, age, tissue permeability, immunological 
factors and implant characteristics (material roughness 
and porosity, chemical reactions, corrosion properties, 
toxicity) [7]. 
  Biocompatibility  estimation  imposes  the 
knowledge of the irritative effect, systemic toxicity level, 
allergic effect, material stability in the physiologic medium 
and the possible interactions between cell constituents 
and the implanted material [8]. The testing program must 
be chosen depending on polymer nature, implant form, 
implant location and the length of time for implant keeping 
in the organism. The testing program includes three 
stages, respectively preclinical testing, animal 
implantation and clinical testing on human subjects. 
Biocompatibility testing is a sine qua non condition of 
biomedical polymer use. The great difficulty resides in the 
burden of colligation between polymer supra molecular 
structure and organism physiological medium, considering 
cell and sub cell reactions and hystochemical, physical 
and chemical   aspects of implant accessibility or reject 
[9].  
    A basic request of biomedical engineering is the 
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encountered a tissue reaction to implant even if the 
material is chemically inert.  
    Medical evaluation of the polymer must be 
preceded by tissue and blood compatibility assessment 
and by in vitro and in vivo tests, individualized for each 
polymer [10].  
Although  in vivo experiments are much more 
conclusive, due to higher costs and laborious techniques, 
there are mainly used a series of in vitro tests [11].  
The goal of our study was to evaluate the in vitro 
biocompatibility of some synthetic polymers (Polyvinyl 
alcohol-APV, Polyethylene glycol-PEG and polyvinyl 
chloride-PVC), by using fibroblast cultures in order to use 
them for the achievement of nervous conduits. In neural 
tissue engineering, degradable materials are preferred 
whenever possible due to their low incidence of 
inflammation and scar - very deleterious for the nerve 
function. The lack of biocompatibility and bioactivity of 
some synthetic polymers prevents them from promoting 
cell attachment, proliferation, and differentiation [12,13].  
In the very specific case of nerve conduits, whatever its 
form of a biologic tube, synthetic tube or tissue-
engineered conduit, it should facilitate neurotropic and 
neurotrophic communication between the proximal and 
distal ends of the nerve gap, block external inhibitory 
factors, and provide a physical guidance for axonal 
growth [14]. The management of peripheral nerve injury 
requires a thorough understanding of the complex 
physiology of nerve regeneration, with the ability to 
perform surgery under magnification [15]. Severe nerve 
injuries that led to nerve gaps can be surgically repaired 
either by autografts or nerve guide conduits. Artificial 
nerve guide conduits have the advantage over autografts 
due to their availability and ease of fabrication. However, 
clinical outcomes associated with the use of artificial 
nerve conduits are often inferior to that of autografts, 
particularly over long lesion gaps [16]. 
Although autografts are the gold standard in nerve gap 
repair, they have a series of drawbacks. In order to 
obviate them, some authors reported the use and test of 
ultrathin microporous biodegradable PCL and PCL/PLA 
films for their compatibility with motor neuron-like NG108-
15 cells and primary Schwann cells. 
Immunohistochemical staining showed that regenerated 
nerve tissue and penetrated Schwann cells have the 
potential to span the whole length of the conduit in 2 
weeks [17]. 
In humans, the studies are rather limited to short 
gaps but quite encouraging for sensitive nerve, proving 
that collagen conduits are an effective treatment for post-
traumatic painful neuromas of digital nerves and common 
digital nerves [18]. 
Methods 
Polymeric materials 
PVC for medical use has relative molecular mass of 
25000 Da and a polymerization degree of 70; it was 
obtained by polymerization in suspension (OLTCHIM 
Ramnicu Valcea, Romania). APV has relative molecular 
mass of 71000 Da and a polymerization degree of 1600 
and it was obtained from ROMACRIL Rasnov SA, 
Romania. PEG is from SERVA and it has relative 
molecular mass of 4000 Da and a polymerization degree 
of 70. 
 
Cell culture testing 
PVC, APV and PEG in vitro biocompatibility was 
evaluated by fibroblast culture testing (MRC5 – human 
lung fibroblasts). The culture medium was represented by 
DMEM, supplemented with a 10% foetus calf serum and a 
3 antibiotic mix: penicillin, streptomycin and neomycin. 
 
Cell proliferation determination 
The cytotoxic effect of polymeric materials was 
measured by the MTT test. 
MTT test (3-4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) is based on tetrazolium 
soluble salt conversion in formazan with the help of 
mytocondrial NAD and NADH-dehydrogenases from the 
viable cells. 
In order to achieve the PVC, APV and PEG 
extracts, samples from each polymer (sterilized by an 8 
hour UV radiation exposure) were immersed in a DMEM 
medium, supplemented with a 10% foetus calf serum, for 
24 hours, at an extraction report of 6 cm2 sample/1 ml 
medium (PVC and APV) and 3 mg PEG/1 ml medium. 
For the experiment, the cells were seed at a 
2,5x104 cell/ml density in 24 well plates and incubated in a 
humid atmosphere with 5% CO2, at 370C, for 24 hours. 
After incubation, the culture medium was replaced with 
the medium that contained the polymer extracts. After 24, 
respectively 48 hours of culture within the polymer 
extracts, we added the MTT reactive. After 3 hours of 
culture in the dark, the formed formazan crystals were 
made soluble by isopropanol and the absorbance in the 
holes was measured at 570 nm. 
The percent of viable cells cultured with the 
polymer extracts was calculated by reporting to a control 
sample (cells cultured without the extract) considered as 
having a viability of 100%. 
 
Cell morphology determination 
Qualitative biocompatibility analysis was done by 
comparing the morphology of MRC5 fibroblast cultured 
with the PVC, APV and PEG samples to control cell 
cultures. 
For cell morphology analysis, cells cultured with 
the polymer extracts for 48 hours were washed with PBS, 
fixed with methanol at -200C, colored with Giemsa 
solution according to von Gieson method, visualized at a 
Zeiss inversed microscope and then photos were taken.  
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Results  
The biocompatibility of PVC, APV and PEG was 
evaluated in vitro by measuring the mitochondrial 
dehydrogenase activity (MTT test) and by the analysis of 
cell morphology of the fibroblasts cultured in indirect 
contact with these synthetic polymeric materials (extract 
samples). Experiments were carried in a cell culture 
laboratory accredited by RENAR in accordance with SR 
EN ISO 17025:2005 standard requirements to determine 
the cytotoxicity of the medical devices by quantitative and 
qualitative methods. 
The results for cell proliferation with MTT test for 
PVC are presented in Fig.1. 
 
 
 
 
 
 
The results were based on MTT absorption and 
reflected mitochondrial activity in the viable cells. A cell 
viability percent higher than 80% signified a good 
biocompatibility for the tested polymer - PVC.  
Cell morphology analysis was realized by 
comparing the morphology of fibroblasts that were 
cultured with PVC samples to the control cells. 
The control fibroblasts presented a normal 
phenotype. The cells had a stellate or elliptic form, with a 
normal colored nucleus, 2-3 prominent nucleoli and the 
cytoplasm was granulated. The fibroblasts cultured with 
the PVC samples remained normal after the culture 
period, demonstrated by light microscopy at 24 and 48 
hours (Fig. 2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These tests confirmed the fact that the analyzed 
PVC sample did not present cytotoxic effect and did not 
inhibit cell proliferation, having a satisfactory degree of 
biocompatibility as compared to the control group. 
The results of MTT test for APV are presented in Fig. 3. 
 
 
 
 
 
 
 
Cell viability was the highest for those ones 
incubated with the APV extract (over 85%), as compared 
both to the control sample and the other polymers 
samples tested.  
For cell morphology analysis, the images taken 
for the APV sample were compared to the control images 
(cell culture without the polymer) (Fig. 4). The analysis of 
cell morphology showed that the cells incubated with the 
APV extract did not exhibit different aspects, fibroblasts 
presenting, in their vast majority, a normal phenotype.  
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Fig.1. Fibroblast viability in presence of PVC extract after 
24 and 48 hours of culture. 
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Fig. 2. Light microscopy images of cell cultures after 24 
hours. A – control sample; B - PVC sample 
 
Fig. 3. Cell proliferation test (MTT) at 24 and 48 hours in 
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APV biocompatibility tests showed that this 
polymer had a good degree of biocompatibility, because it 
did not inhibit cell proliferation and did not lead to 
morphology changes for a significant number of cells.  
In Fig. 5 we present the degree of cell proliferation for 
PEG, at 24 and 48 hours, evaluated by MTT test.   
 
 
 
 
 
 
Cell viability was lower for those ones incubated 
with the PEG extract, as compared to the control, but it is 
higher than 80% after both periods of time.  
The images for the morphologic analysis tests 
for PEG sample were compared to the control sample 
(the cell culture without the polymer) (Fig. 6). The cells 
incubated with the PEG extract had a normal aspect, 
similar to the control sample, namely they were slightly 
elliptic and had a well-differentiated nucleus and 2-3 
prominent nucleoli. However, the cells cultured in the 
presence of this polymer extract showed a small 
proportion of apoptotic cells as compared to the control 
sample that showed no changes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results achieved for PEG showed a good in vitro 
degree of biocompatibility, slightly lower than the control 
samples.  
Discussions 
The biocompatibility of 3 synthetic polymers was 
tested: Polyvynilic alcohol (APV), Polyethylene glycol 
(PEG) and Vynil polychloride (PVC). PVC is one of the 
mainly used medical materials due to its multiple 
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Fig. 4. Light microscopy images of cell cultures after a 48 
hours period of culture with the APV extract (B) and without 
it (control sample - A). 
Fig. 5. Cell proliferation test (MTT) at 24 and 48 hours. 
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Fig. 6. Light microscopy images of cell cultures after 48 
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properties: flexibility, bending resistance, compactness, 
chemical and biological resistance, gamma irradiation, 
ethylene oxide and autoclave sterilization.  
APV presents a special interest due to its 
characteristics that recommends it for numerous medical 
and pharmaceutical applications. Its long lifetime in the 
organism is due to the lack of tissue disintegration. APV 
multiple uses, including peripheral nerve surgery, is based 
on its physical and chemical properties: water solubility, 
thermical stability, film making capacity, stretching 
resistance, organic solvents and oil  resistance, good 
biodegradability, nontoxicity  and non carcinogenicity.  
PEG is the most important commercial synthetic 
polymer. It is achieved by suspension polymerization of 
ethylene oxide and is purchased under liquid or solid 
form, with a molecular weight between 300 and 10 000 
000 g/ml. The polymerization initiator induces these 
polymers, in different forms. PEG has a low toxicity and 
thus a large applicability in clinical and pharmaceutical 
domain. Recent studies emphasized PEG use for gene 
therapy vectors encapsulation. PEG hydrogels are 
tolerated in CNS, also. It was demonstrated that neural 
precursor cells were able to be photoencapsulated and 
cultured on the PEG gels with minimal cell death. The 
hydrogel blocks inflammatory and other inhibitory signals 
from surrounding tissue and is able to serve as a scaffold 
for axon regeneration [12]. 
The in vitro tests for the above three polymers 
were performed on a stabilized fibroblast culture (MRC5). 
There were evaluated cell viability and morphology for 
those cells that were in indirect contact with the studied 
polymers.  
These tests concluded that although all the three 
tested synthetic polymers were biocompatible, their 
degrees of biocompatibility varied. Cell viability was over 
80% for all studied synthetic polymers. The degree of 
proliferation was the highest for the cells incubated in the 
presence of APV sample (over 85%), as compared to the 
other polymers samples tested (PVC, PEG). Thus, we 
could frame them all in the biocompatible material 
category. Cell morphology did not significantly change: 
this represented also a biocompatibility criterion.  
After establishing the biocompatibility, the next 
step is represented by studies regarding the association, 
by covering or mixing, of biopolymers with the analysed 
synthetic polymers in order to achieve new biomaterials 
with application in peripheral nerve surgery for nervous 
conduits manufacture. Besides new biomaterials, of 
interest is also the development of novel conduit 
architectural designs using porous and fibrous substrates 
[16]. Another beneficial influence on peripheral nerve 
regeneration was demonstrated to be accomplished by 
multichannel guidance conduits due to the limited 
dispersion that did not decreased the quantitative results 
of regeneration [19]. 
Despite the advancements in the field of tissue 
engineering, the level of functional improvement after 
peripheral nerve injuries did not increased. However, 
there are emerging hopes for the next generation of nerve 
conduits with the advancement of nanotechnology [15]. 
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